Summarised points made in the discussion about the INCB report and addressed some the concerns made by Argentina about the INCB report containing the wrong statistics. Reaffirmed the need for members states to stick within the 3 drug conventions and made a final reference to complying with international human rights standards.
From Plenary Sessions
WHO comment on access to controlled medicines
Lack of access to essential controlled medicines is still a major issue especially in low income countries. Countries need to aim for a balanced policy. WHO provides technical assistance to countries to access medicines while ensure controlled medicines aren’t used outside of medical settings.
Japan comment on NPS and Cannabis seeds
Glad UNODC is addressing cannabis seeds and NPS issue. We have a deep concern about medical use of cannabis in certain countries and will pose a serious impact of cannabis control. WE support INCB in expressing concern on this issue
NPS comment – Australia
Australia: We are pleased this debate is on the agenda and that its been included in the INCB report. Its a global issue and many places are implementing measures to address the issue. Need an early warning system to enable efficient use of limited resources. Australia giving 200,000 USD for the global early warning system.
Comments on INCB report by Switzerland, Thailand, USA.
Switzerland: Regular criminal proceedings are dispensed with, saving n costs and easing pressure on police. People who are 18 or older will be a fined 100 swiss frans. no more than 10 grams. HIV and IDU are a major issue, and we recommend the INCB make more of an issue on this in future reports. Thailand: Concerned …
Comments on INCB report 2012 by Japan
Raises concern about lack of controls on Ketamine and implies the INCB/WHO should make a balanced assessment